GlassScriptPhysician profile
Elmo Baldassari
NPI 1497799415
$4,665.99
in general payments reported to CMS, 2019-2025
15 companies · $1,555 in 2025
The $1,555 reported for 2025 was more than what 79% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $493 · 2020: $168 · 2021: $1,539 · 2022: $514 · 2023: $208 · 2024: $190 · 2025: $1,555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,496 · Travel and Lodging: $457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,495.54 |
| Travel and Lodging | $457.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,324.22 | 2019-2025 | Flexband, Augment Injectable, Infinity Adaptis |
| Organogenesis INC. | $512.26 | 2021-2024 | Puraply |
| Smith+Nephew, INC. | $396.45 | 2020-2025 | Grafix Pl, Oasis, Stravix Pl |
| Novus Surgical Solutions LLC | $67.57 | 2021-2022 | |
| Linvatec Corporation | $61.50 | 2021-2023 | Colink Plating System, 5ms |
| Integra Lifesciences Corporation | $60.72 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Novastep INC. | $54.12 | 2021 | |
| Abbott Laboratories | $48.45 | 2025 | Proclaim |
| Novus Surgical Consultants | $40.56 | 2024-2025 | |
| Paratek Pharmaceuticals, INC. | $34.39 | 2022-2023 | Nuzyra |
| Convatec INC. | $16.28 | 2024 | |
| Djo, LLC | $14.59 | 2021 | |
| Abbvie INC. | $11.66 | 2021 | |
| Pfizer INC. | $11.65 | 2021 | |
| Merck Sharp & Dohme LLC | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elmo Baldassari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.